Development of a Core Outcome Set for Fetal Hydrocephalus (COSHydro)

Fetal hydrocephalus is a relatively common prenatal diagnosis associated with perinatal mortality and long-term neurodevelopmental impairment. Studies of its natural history and of prenatal and postnatal treatments report heterogeneous outcomes, defined and measured in different ways and at different time points, which prevents comparison between studies and evidence synthesis. No core outcome set (COS) exists for this condition. This project aims to develop a COS for studies of prenatally diagnosed fetal hydrocephalus, including trials of prenatal intervention, incorporating the views of parents, people living with hydrocephalus, healthcare professionals and researchers, following the COMET Handbook and COS-STAD recommendations.

Contributors

Principal investigator: Alireza A. Shamshirsaz – Comprehensive Fetal Care Center, Dell Children's Medical Center; Division of Fetal Medicine and Therapy, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.

Further Study Information

Current Stage: Ongoing
Date: February 2026 - 2027
Funding source(s): No funding sources


Health Area

Disease Category: Pregnancy & childbirth

Disease Name: Fetal hydrocephalus (prenatally diagnosed severe ventriculomegaly)

Target Population

Age Range: 0 - 10

Sex: Either

Nature of Intervention: Any

Stakeholders Involved

- Clinical experts
- Consumers (caregivers)
- Consumers (patients)
- Families
- Researchers

Study Type

- COS for clinical trials or clinical research
- COS for practice

Method(s)

- Consensus meeting
- Delphi process
- Interview
- Literature review
- Survey
- Systematic review

(1) Systematic review of outcomes reported in studies of prenatally diagnosed fetal ventriculomegaly or hydrocephalus (ongoing; PROSPERO CRD420261517158).
(2) Semi-structured interviews with parents/caregivers and adults living with congenital hydrocephalus to identify additional outcomes; the steering committee will merge, classify (COMET outcome taxonomy) and finalize the long list, with plain-language descriptions and a pilot of the questionnaire.
(3) Three-round international online Delphi survey with three stakeholder panels: (A) parents, caregivers and people with lived experience; (B) professionals in prenatal care and fetal therapy; (C) professionals in neonatal, neurosurgical, neurological and long-term care. Outcomes scored on the GRADE 9-point scale, with feedback by panel between rounds. Consensus in: =70% scoring 7–9 and <15% scoring 1–3 in every panel. Target =120 participants in round 1 (=40 per panel).
(4) Consensus meeting using a modified nominal group technique with anonymous voting to agree the final COS and outcome definitions.
Selection of outcome measurement instruments will follow in a separate step (COSMIN–COMET guideline).

Linked Studies

    No related studies


Related Links

    No related links